« Back to Record
Berghmans, T., Lafitte, J.-J., Paesmans, M., Meert, A.-P., Scherpereel, A., Leclercq, N., & Sculier, J.-P. (2011). A phase III randomised trial assessing the activity of first –line ifosfamide-gemcitabine (IG), a non platinum chemotherapy (CT), in patients with advanced non small cell lung cancer (NSCLC). The European respiratory journal.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/112538



